[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611950":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":22,"locations":32,"responsibleParty":85,"collaborators":88,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":96,"sex":102,"minAge":103,"maxAge":104,"enrollmentInfo":105,"targetDuration":21,"studyType":108,"phases":109,"briefSummary":111,"conditions":112,"keywords":115,"overallStatus":117,"whyStopped":21,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"Asan Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Inhaled Nitric Oxide","EXPERIMENTAL","Administration of inhaled NO in newborn infants with CDH approaching predefined criteria of pulmonary hypertension and hypoxic respiratory failure",[13],"Drug: Inhaled Nitric Oxide",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Inhalation of nitric oxide for 30 minutes in CDH approaching predefined criteria of moderate to severe pulmonary hypertension and define the short-term response",[9],[20],"iNO, Nitric Oxide gas",null,[23,28],{"name":24,"role":25,"phone":26,"phoneExt":21,"email":27},"Byong Sop Lee, MD, PhD","CONTACT","82-2-3010-3929","mdleebs@amc.seoul.kr",{"name":29,"role":25,"phone":30,"phoneExt":21,"email":31},"Euiseok Jung, MD, PhD","82-2-3010-3372","euisjung@amc.seoul.kr",[33,49,63,74],{"facility":5,"status":21,"city":34,"state":34,"zip":35,"country":36,"countryCode":21,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Seoul","05505","South Korea",{"type":38,"coordinates":39},"Point",[40,41],126.9784,37.566,{"lat":41,"lon":40},[44,45,47],{"name":24,"role":25,"phone":26,"phoneExt":21,"email":27},{"name":24,"role":46,"phone":21,"phoneExt":21,"email":21},"PRINCIPAL_INVESTIGATOR",{"name":29,"role":48,"phone":21,"phoneExt":21,"email":21},"SUB_INVESTIGATOR",{"facility":50,"status":21,"city":51,"state":21,"zip":52,"country":36,"countryCode":21,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Chonnam National University Hospital","Gwangju","44935",{"type":38,"coordinates":54},[55,56],126.91556,35.15472,{"lat":56,"lon":55},[59],{"name":60,"role":25,"phone":61,"phoneExt":21,"email":62},"Eun-Song Song, MD","82-2-2206646","dab-77@hanmail.net",{"facility":64,"status":21,"city":34,"state":21,"zip":65,"country":36,"countryCode":21,"cosmosGeoPoint":66,"geoPoint":68,"contacts":69},"Seoul National University Children's Hospital","03080",{"type":38,"coordinates":67},[40,41],{"lat":41,"lon":40},[70],{"name":71,"role":25,"phone":72,"phoneExt":21,"email":73},"Seung Han Shin, MD, PhD","82-2-1588-5700","revival421@snu.ac.kr",{"facility":75,"status":21,"city":34,"state":21,"zip":76,"country":36,"countryCode":21,"cosmosGeoPoint":77,"geoPoint":79,"contacts":80},"Severance Hospital","03722",{"type":38,"coordinates":78},[40,41],{"lat":41,"lon":40},[81],{"name":82,"role":25,"phone":83,"phoneExt":21,"email":84},"Ho Sun Eun, MD","82-2-2228-5966","HSEUN@yuhs.ac.kr",{"type":46,"investigatorFullName":86,"investigatorTitle":87,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"Byong Sop Lee","Professor, Department of Pediatrics",[89,91,92],{"name":90,"class":6},"Seoul National University Hospital",{"name":75,"class":6},{"name":93,"class":6},"Chungnam National University Hospital","100611950","phase-4-efficacy-of-inhaled-nitric-oxide-in-congenital-diaphragmatic-hernia-100611950",false,"NCT07247240","Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia","Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia With Early Pulmonary Hypertension","INOCDH","Inclusion Criteria:\n\n* Bochdalek type congenital diaphragmatic hernia\n* Gestational age at 34 weeks or more and within 14 days after birth\n* Hypoxic respiratory failure and pulmonary hypertension\n\nExclusion Criteria:\n\n* Combined congenital heart disease requiring neonatal intervention or surgery\n* Previous treatment of pulmonary vasodilators including inhaled nitric oxide\n* on ECMO treatment","ALL","1 Minute","14 Days",{"count":106,"type":107},40,"ESTIMATED","INTERVENTIONAL",[110],"PHASE4","This multicenter, prospective, single-arm study aims to evaluate the efficacy of inhaled nitric oxide (iNO) in neonates with congenital diaphragmatic hernia (CDH) and early pulmonary hypertension. Short-term treatment response will be assessed by the changes in oxygenation index and other parameters including echocardiographic parameters at predefined intervals.",[113,114],"Congenital Diaphragmatic Hernia","Pulmonary Hypertension",[113,116,114],"Nitric Oxide","NOT_YET_RECRUITING","2025-11-23",{"date":120,"type":121},"2025-11-25","ACTUAL",{"date":123,"type":107},"2025-11",{"date":125,"type":107},"2028-12",{"name":5,"class":6},4]